Patents by Inventor Roberto Angeli

Roberto Angeli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11354967
    Abstract: There is described a precision dispenser for liquids, in particular medications, which allows the remote control of all operations associated with dispensing the medication to the patient so as to avoid abuses.
    Type: Grant
    Filed: December 28, 2020
    Date of Patent: June 7, 2022
    Inventor: Roberto Angeli
  • Publication number: 20210118542
    Abstract: There is described a precision dispenser for liquids, in particular medications, which allows the remote control of all operations associated with dispensing the medication to the patient so as to avoid abuses.
    Type: Application
    Filed: December 28, 2020
    Publication date: April 22, 2021
    Inventor: Roberto Angeli
  • Patent number: 10922382
    Abstract: There is described a precision dispenser for liquids, in particular medications, which allows the remote control of all operations associated with dispensing the medication to the patient so as to avoid abuses.
    Type: Grant
    Filed: March 1, 2017
    Date of Patent: February 16, 2021
    Assignee: L. MOLTENI & C. DEI FRATELLI ALITTI—SOCIETE DI ESERCIZIO S.P.A.
    Inventor: Roberto Angeli
  • Publication number: 20180025129
    Abstract: There is described a precision dispenser for liquids, in particular medications, which allows the remote control of all operations associated with dispensing the medication to the patient so as to avoid abuses.
    Type: Application
    Filed: March 1, 2017
    Publication date: January 25, 2018
    Inventor: Roberto Angeli
  • Publication number: 20150374499
    Abstract: The present subject matter relates to a femoral component of a hip prosthesis consisting of two parts; a superior (metaphyseal) portion made from biocompatible, non-bioabsorbable material, and an inferior (diaphyseal) portion which is bioabsorbable. The diaphyseal portion will be absorbed by the organism months after implantation thereof, which is the necessary time for definitive attachment of the metaphyseal portion in a suitable position by osseointegration. This assembly allows perfect alignment of the prosthesis during the surgical procedure, the diaphyseal shank acting as a guide in the femoral canal, and due to the small size thereof will enable removal of the superior portion if revision surgery is necessary.
    Type: Application
    Filed: November 13, 2013
    Publication date: December 31, 2015
    Inventor: José Roberto ANGELI
  • Publication number: 20150344290
    Abstract: A distributor of liquid methadone comprising a cooling device appropriately arranged in the hydraulic circuit is described.
    Type: Application
    Filed: July 24, 2014
    Publication date: December 3, 2015
    Inventor: Roberto ANGELI
  • Patent number: 8664381
    Abstract: The present invention relates to a process for the purification of amorolfine hydrochloride by means of a reversed-phase preparative high performances liquid chromatography (prep-HPLC) said method starting from a crude Amorolfine hydrochloride having purity higher than 90% and containing Bepromoline hydrochloride <5% and Fenpropimorf <3%. The process involves the use of a mobile phase comprising water and an organic solvent under isocratic conditions.
    Type: Grant
    Filed: February 18, 2010
    Date of Patent: March 4, 2014
    Assignee: SYNTECO S.p.A.
    Inventors: Roberto Angeli, Marco Possenti, Salvatore Demartis
  • Publication number: 20130059876
    Abstract: Liquid formulations for administration of naltrexone at low concentrations by the nasal route are described.
    Type: Application
    Filed: May 20, 2011
    Publication date: March 7, 2013
    Applicant: L Molteni & C Dei Fratelli Alitti Societa Di Esercizio S.p.A
    Inventors: Roberto Angeli, William Raffaeli, Maria Adele Rigamonti
  • Publication number: 20130011479
    Abstract: Immediate-release formulations are described, consisting of double-layer tablets wherein one layers contains an opioid agonist and the other an opioid antagonist.
    Type: Application
    Filed: March 23, 2011
    Publication date: January 10, 2013
    Applicant: L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO S.p.A
    Inventors: Roberto Angeli, William Raffaeli, Maria Adele Rigamonti
  • Publication number: 20110301346
    Abstract: The present invention relates to a process for the purification of amorolfine hydrochloride by means of a reversed-phase preparative high performances liquid chromatography (prep-HPLC) said method starting from a crude Amorolfine hydrochloride having purity higher than 90% and containing Bepromoline hydrochloride <5% and Fenpropimorf <3%. The process involves the use of a mobile phase comprising water and an organic solvent under isocratic conditions.
    Type: Application
    Filed: February 18, 2010
    Publication date: December 8, 2011
    Applicant: SYNTECO S.P.A.-PRODOTTI DI SINTESI PER L'INDUSTRIA CHIMICA E FARMACEUTICA
    Inventors: Roberto Angeli, Marco Possenti, Salvatore Demartis